Adoprazine5-HT1A receptor agonist and full D2/3 receptor antagonist CAS# 222551-17-9 |
- Granisetron HCl
Catalog No.:BCC1060
CAS No.:107007-99-8
- Vilazodone
Catalog No.:BCC2040
CAS No.:163521-12-8
- SB 271046 hydrochloride
Catalog No.:BCC1924
CAS No.:209481-24-3
- SEA0400
Catalog No.:BCC1941
CAS No.:223104-29-8
- Tianeptine
Catalog No.:BCC1999
CAS No.:66981-73-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 222551-17-9 | SDF | Download SDF |
PubChem ID | 9887537 | Appearance | Powder |
Formula | C24H24FN3O2 | M.Wt | 405.46 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 50 mg/mL (123.32 mM; Need ultrasonic) H2O : < 0.1 mg/mL (insoluble) | ||
Chemical Name | 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-4-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]piperazine | ||
SMILES | C1CN(CCN1CC2=CN=CC(=C2)C3=CC=C(C=C3)F)C4=C5C(=CC=C4)OCCO5 | ||
Standard InChIKey | IUVSEUFHPNITEQ-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C24H24FN3O2/c25-21-6-4-19(5-7-21)20-14-18(15-26-16-20)17-27-8-10-28(11-9-27)22-2-1-3-23-24(22)30-13-12-29-23/h1-7,14-16H,8-13,17H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Adoprazine Dilution Calculator
Adoprazine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4663 mL | 12.3317 mL | 24.6633 mL | 49.3267 mL | 61.6584 mL |
5 mM | 0.4933 mL | 2.4663 mL | 4.9327 mL | 9.8653 mL | 12.3317 mL |
10 mM | 0.2466 mL | 1.2332 mL | 2.4663 mL | 4.9327 mL | 6.1658 mL |
50 mM | 0.0493 mL | 0.2466 mL | 0.4933 mL | 0.9865 mL | 1.2332 mL |
100 mM | 0.0247 mL | 0.1233 mL | 0.2466 mL | 0.4933 mL | 0.6166 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Adoprazine is a full 5-HT1A receptor agonist and full D2/3 receptor antagonist possessing characteristics of an atypical antipsychotic, representing a potential novel treatment for schizophrenia.
- Loganic acid
Catalog No.:BCN5057
CAS No.:22255-40-9
- Lucidin 3-O-glucoside
Catalog No.:BCN8249
CAS No.:22255-29-4
- Trimethoxystilbene
Catalog No.:BCN6762
CAS No.:22255-22-7
- Guaijaverin
Catalog No.:BCN5056
CAS No.:22255-13-6
- alpha-Amyrin palmitate
Catalog No.:BCN5055
CAS No.:22255-10-3
- Methyl 6-hydroxyangolensate
Catalog No.:BCN5054
CAS No.:22255-07-8
- Ipratropium Bromide
Catalog No.:BCC3795
CAS No.:22254-24-6
- 7-Amino-3-methyl-3-cephem-4-carboxylic acid
Catalog No.:BCC8776
CAS No.:22252-43-3
- Fern-7-en-19-one
Catalog No.:BCN6443
CAS No.:222294-61-3
- Thalrugosaminine
Catalog No.:BCN7745
CAS No.:22226-73-9
- Cucurbitacin I
Catalog No.:BCC2439
CAS No.:2222-07-3
- Dehydroglaucine
Catalog No.:BCN2548
CAS No.:22212-26-6
- Tempol
Catalog No.:BCC4862
CAS No.:2226-96-2
- Bromocriptine mesylate
Catalog No.:BCC6642
CAS No.:22260-51-1
- Antidesmone
Catalog No.:BCN5058
CAS No.:222629-77-8
- ACBC
Catalog No.:BCC6584
CAS No.:22264-50-2
- Chysin A
Catalog No.:BCN2020
CAS No.:22269-11-0
- SZL P1-41
Catalog No.:BCC8004
CAS No.:222716-34-9
- Noladin ether
Catalog No.:BCC5756
CAS No.:222723-55-9
- Finasteride acetate
Catalog No.:BCC4204
CAS No.:222989-99-3
- SEA0400
Catalog No.:BCC1941
CAS No.:223104-29-8
- Inolitazone
Catalog No.:BCC1652
CAS No.:223132-37-4
- Inolitazone dihydrochloride
Catalog No.:BCC1653
CAS No.:223132-38-5
- Evodol
Catalog No.:BCN5059
CAS No.:22318-10-1
Synthesis and dual D2 and 5-HT1A receptor binding affinities of 7-piperazinyl and 7-piperidinyl-3,4-dihydroquinazolin-2(1H)-ones.[Pubmed:24024527]
Med Chem. 2014;10(5):484-96.
A series of new 7-piperazinyl and 7-piperidinyl-3,4-dihydroquinazolin-2(1H)-ones has been synthesized. The described compounds are structurally related to Adoprazine, a potential atypical antipsychotic bearing potent D2 receptor antagonist and 5-HT1A receptor agonist properties. Suitably modified aryl bromides were prepared and condensed with tert-butyl piperazine-1-carboxylate to afford the advanced intermediate piperazinyl-3,4-dihydroquinazolin-2(1H)-one. Likewise Suzuki-Miyaura cross-coupling reaction of cyclic vinyl boronate with appropriate aryl bromides rendered piperidinyl-3,4-dihydroquinazolin-2(1H)-one. The reductive amination of the piperazinyl and piperidinyl-3,4- dihydroquinazolin-2(1H)-ones with suitably designed biarylaldehydes accomplished the synthesis of these title compounds. The described compounds were screened for D2 and 5-HT1A receptors binding affinities. The structure-activity relationship studies revealed that cyclopentenylpyridine and cyclopentenylbenzyl groups contribute significantly to the dual D2 and 5-HT1A receptor binding affinities of these compounds.